The FDA has granted Fast Track designation to PP-007 (PEGylated carboxyhemoglobin, bovine) for the treatment of acute ischemic stroke.
Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The conference call to review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback